An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1
about
Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infectionSTRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by NefA lectin isolated from bananas is a potent inhibitor of HIV replicationSmall interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral productionIdentification of the 15FRFG domain in HIV-1 Gag p6 essential for Vpr packaging into the virionHIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategiesSensitivity to a nonpeptidic compound (RPR103611) blocking human immunodeficiency virus type 1 Env-mediated fusion depends on sequence and accessibility of the gp41 loop regionMultibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophagesPersistent infection of macaques with simian-human immunodeficiency virusesProtection of stem cell-derived lymphocytes in a primate AIDS gene therapy model after in vivo selection.Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigensProtection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism.A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer.CD56+ T cells inhibit HIV-1 infection of macrophagesDistinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytesCXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usageThe cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes.Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia.Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate.In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques.Human immunodeficiency virus neurotropism: an analysis of viral replication and cytopathicity for divergent strains in monocytes and microglia.Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1.Virion-targeted viral inactivation of human immunodeficiency virus type 1 by using Vpr fusion proteins.Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells.Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: role of the V1/V2 domainsThe antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production.Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacy.N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates.CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants.Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolatesGenetic variation and HIV-associated neurologic disease.Efficient entry inhibition of human and nonhuman primate immunodeficiency virus by cell surface-expressed gp41-derived peptides.Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolatesGlycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation
P2860
Q22251080-AB3D5A88-6E2D-4854-B477-48C3C787E526Q24324020-22AA9A22-83C8-4A25-A077-6C2F10262778Q24338889-EC435996-2766-4D8C-802D-A2A49A7D9C70Q24629155-1BF512B6-D848-47CA-95C4-91E8E9A703ECQ24682936-585A2BE4-8DD4-41FE-92CD-9EB44BB038D3Q24797248-730F41DF-65F9-4604-B691-ED2ED6C337ECQ26825087-5429E0F5-32E8-4FF3-992D-CE4E158A73FDQ28343901-71C8A89C-76D2-44BD-95D8-F2D948B805B5Q28369349-EBC1A9EB-BF73-4210-A6EC-21FC975259FBQ28775731-83836F4E-FE72-45F0-8791-98C7E5EB2DB2Q33514823-DD6E2EE5-CCE0-4E09-AABE-2199766B5476Q33603483-7B641617-E6EB-4458-982A-5BFFFEDAD4B7Q33647300-8A1A63ED-7720-4E49-91CB-33062C1F2161Q33648601-7F9FDAC7-6A4A-40C8-B2EA-1A84E1F06C45Q33725702-E77BCA72-1C5D-44C4-8E0B-FE042D4812C7Q33730835-2121E2C2-A6AD-456E-81DA-EB43A5E765CDQ33782118-3BD93F58-753B-40E6-AF08-71BDCD4647BEQ33782165-3E84AB86-D9B5-403E-9D53-A0C97D7CCCDAQ33782296-A9BF468A-6017-44F9-8F16-26F28748B293Q33782350-5CCE9673-F864-4EBC-94E0-E65E0CDA9367Q33782530-376FE1CB-E333-4EC1-9628-A40298081B42Q33782833-470C3E6F-606D-4C59-9D3F-2D8D5F55953AQ33782925-8BBE80EC-06BD-4DBF-8DE5-A3A8E54F00D5Q33783369-B54BA98E-0473-4F69-87DF-3EF2626C011BQ33783434-BDCC2F4D-A080-456D-9A13-3B5E7D34AC0AQ33783516-DBEF8D35-5C82-443C-B835-1F3CEDF85254Q33784907-86FC6B07-167B-4274-A5CE-9B92B20772BEQ33787335-1DCEE901-3E60-4FC1-BFB5-AE07BD9410A8Q33796067-9AA8145F-5D91-4A40-85B1-A51956A92D2AQ33802684-90A5ABD4-3BCD-49ED-A412-70DD1CBEE36BQ33803217-3504051D-6D28-418D-94E9-F8F320BE884CQ33804016-8D10B6CE-4FF3-44EB-9E71-2133CEF33938Q33804193-4335AED7-7F60-4EF9-A243-51B4E4D0DAE5Q33816465-74595AAF-47A8-4FBF-A4BF-6AB974FE959FQ33817249-53281E11-A22B-4047-A90A-A387522F86FCQ33819189-2153B7C0-385A-4998-B14A-7F001DFB697AQ33822282-C2CD628D-B7F4-49F3-9058-46646BC7AB98Q33824289-893EF105-5700-4316-8E44-8644F829DA07Q33826382-F8D04CD4-913A-42A2-88C2-C0246D8B9B63Q33842620-7ED00434-0C77-4CC3-85E8-2E77525F9C77
P2860
An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
An infectious molecular clone ...... immunodeficiency virus type 1
@ast
An infectious molecular clone ...... immunodeficiency virus type 1
@en
type
label
An infectious molecular clone ...... immunodeficiency virus type 1
@ast
An infectious molecular clone ...... immunodeficiency virus type 1
@en
prefLabel
An infectious molecular clone ...... immunodeficiency virus type 1
@ast
An infectious molecular clone ...... immunodeficiency virus type 1
@en
P2093
P2860
P1433
P1476
An infectious molecular clone ...... immunodeficiency virus type 1
@en
P2093
A Srinivasan
D L Kolson
H Friedman
J W Balliet
N Nathanson
S A Gregory
P2860
P304
P407
P577
1992-12-01T00:00:00Z